XO Life is paving the future for patient insights

From the leading reporting platform for drug safety to the largest patient insights platform — how we add patient insights to healthcare and make application-accompanying data collection a standard for every medication and illness. What role does ImpactMonitor play in this and how are we influencing digital health and precision medicine of tomorrow?

What standards are we setting by technologizing and digitizing exchange?

‍

Real-world evidence platform for patient experiences

XO Life aims to be the leading patient insights platform for generating Real-world evidence to create (RWE) for healthcare. To this end, we have created an innovative, multi-directional communication platform that unites patients and healthcare stakeholders. Health professionals can present relevant information to patients or users in a dynamic format. At the same time, patients or users can systematically collect relevant information on all issues of a medication or illness, such as effectiveness or use, in everyday life.

The collected data is pseudonymized, standardized and structured and made available to various actors, such as research institutes and manufacturers, for research and development. The aim is to create a large data base based on directly collected patient experiences from the real care setting. This has the advantage that questions can be answered concretely with relevant answers.

‍

We bring real patient experiences to care and help the healthcare industry better understand its actual end customers — patients.

XO Life — the leading reporting platform for drug safety

After almost 2 years of development work, we have become the leading reporting platform for patient side effects. Our digital reporting platform sets standards for what direct, user-friendly and, above all, time-saving communication between all participants in the reporting process will look like.

Reports are pseudonymized, i.e. without revealing the personal identity of the patients, in accordance with European pharmacovigilance guidelines, digitally and in a standardized manner to the responsible manufacturers. More than 500 manufacturers are already using the platform, of which more than 100 are registered. In doing so, we attach particular importance to redesigning drug safety (pharmacovigilance) with regard to digitization and user orientation. This is where the major advantages of our solution become apparent, for example, the patient response rate of 60% is approximately 10 times higher than the industry average.

Our innovative communication platform fits seamlessly into the existing regulatory monitoring system for drug safety and accompanies the entire process. We are paying particular attention to redesigning pharmacovigilance in terms of digitization and user orientation. This is another reason why we offer our platform technology as Software-as-a-service solution on. Pharmaceutical companies can use their own internal reporting channels, e.g. their website, social media channels, submissions from sales representatives or call centers.

By digitizing and automating processes, not only improved communication but also time savings of up to 95% are possible.

‍

Extension of the platform for all patient insights

Our platform technology and partner network have now reached a level of maturity that we have evolved from a reporting platform for side effects to a real-world evidence platform based on patient insights. In collaboration with one of the leading research institutes in Europe, the PROMIS Institute at Charité, standardized questionnaires were developed to record patient experiences, so-called Patient Reported Outcomes (PRO). In addition, manufacturers are also given the opportunity to ask patients and users their own product or indication-specific questions.

The options offered by our RWEplatform, are limitless: For example, we enable the integration of telemedicine services to consult medical experts. In addition, simple and secure communication channels can be provided between manufacturers and consumers to answer medical inquiries. Safety-relevant information can also be queried via this channel.

Our web application can be used flexibly, including as a white label solution, for proprietary product launches, such as new drug approvals among the population.

With the so-called “ImpactMonitor”, manufacturers can accompany their patients during medication or therapy in accordance with data protection regulations, provide relevant content and at the same time collect significant patient experiences. The possibilities of our Patient Insights platform are almost limitless: For example, we enable the integration of telemedicine services, for example to consult with medical experts. ImpactMonitor is characterized by a quickly available, structured database. It also offers many new opportunities for evaluating health technologies.

Compared to analog data collection in the past, the ImpactMonitor enables data protection-compliant digital support for patients by manufacturers for valuable insights.

‍

XO Life is shaping the future of real-world evidence

After entering the market with a reporting platform for side effects, it is now time to fully realize our vision of a patient insights platform. High data security, data quality and the protection of users' personal data are particularly important to us.

Our goal is for every patient to be accompanied digitally in the best possible way by providing appropriate information and recording their experiences.